Isoginkgetin (4) was reported as a general inhibitor of pre-mRNA splicing [30] and can inhibit HT1080 tumor cell invasion by regulating PI3K/AKT1-dependent matrix metalloproteinase (MMP)-9 expression [18]. The gene discussed is AKT1; the disease is neoplasm.